Accueil / Tag Archives: Product/Service

Tag Archives: Product/Service

AmpliPhi Biosciences Announces Presentation of Personalized Bacteriophage Therapy Case Study for Life-Threatening Antibiotic-Resistant Infection at Scientific Conference

Tuesday, April 25th 2017 at 10:50am UTC Critically ill patient successfully treated with personalized phage therapy under Emergency IND SAN DIEGO–(BUSINESS WIRE)– AmpliPhi Biosciences Corporation (NYSE MKT: APHB), a global leader in the development of therapies for drug-resistant bacterial infections using bacteriophage technology, announces that a case study highlighting the …

Plus »

New Investigational Data on Six-Year Efficacy of Sanofi Genzyme’s Lemtrada® (alemtuzumab) in Multiple Sclerosis Patients Who Experienced Relapse Between Treatment Courses To Be Presented at AAN

Tuesday, April 25th 2017 at 12:00pm UTC Results observed in these patients through six years were similar to those in patients who did not relapse between courses CAMBRIDGE, Mass.–(BUSINESS WIRE)– Sanofi Genzyme, the specialty care global business unit of Sanofi, announced today positive new six-year investigational data from a post-hoc …

Plus »

endpoint Enhances and Extends IRT with Latest Technology Innovation

Tuesday, April 25th 2017 at 12:00pm UTC SAN FRANCISCO–(BUSINESS WIRE)– endpoint Clinical, a leading global interactive response technology (IRT®) company, has announced a significant enhancement to its proprietary PULSE® platform, reshaping the way IRT is applied to clinical trials. “Since the initiation of endpoint in 2009, we have been continuously improving …

Plus »

MolecularMatch Introduces MMPower Knowledge Base – Providing One of the Industry’s Most Dynamic Molecular Search Engines

Monday, April 24th 2017 at 7:42pm UTC HOUSTON–(BUSINESS WIRE)– MolecularMatch has announced their new knowledge platform, MMPower. The Platform covers over 400 million alterations with the ability to process whole exomes in seconds. The complexity of genetic molecular data, in any format, is converted quickly by MMPower into understandable and meaningful information. “We started with some of …

Plus »

Enamine to Collaborate with EMBL for Cancer Drug Discovery Research

Tuesday, April 25th 2017 at 8:25am UTC A strategic agreement between Europe’s flagship laboratory for basic research in molecular biology and the world’s largest medicinal chemistry design house KIEV, Ukraine–(BUSINESS WIRE)– Enamine Ltd., a chemical company, producer of novel chemical building blocks and screening libraries, and the European Molecular Biology Laboratory (EMBL) …

Plus »

Personalis, Inc. Receives Approval from the New York State Department of Health for Clinical Tests Based on the ACE Exome

Monday, April 24th 2017 at 6:15pm UTC Tests based on the ACE Exome have passed Regulatory, Quality Standards, Clinical and Technical review by New York State’s Clinical Laboratory Evaluation Program MENLO PARK, Calif.–(BUSINESS WIRE)– Personalis, Inc., a leading provider of genomic sequencing and genome-based diagnostics for precision medicine, announced today …

Plus »

Dental Anesthesia Providers Improve Efficiency with Streaming Vitals and Paperless Anesthesia EMR from Plexus TG

Tuesday, April 25th 2017 at 1:50pm UTC JACKSON, Mich.–(BUSINESS WIRE)– Plexus Technology Group, LLC (Plexus TG), a market-leading, best-of-breed anesthesia information management systems (AIMS) provider, delivers dental office-based anesthesia providers with a flexible electronic anesthesia record on an iPad, Anesthesia Touch™, that is tailored to their specific workflow. By automating …

Plus »

Introducing Tylactin Complete Bars for Tyrosinemia (TYR)

Tuesday, April 25th 2017 at 1:00pm UTC AYER, Mass.–(BUSINESS WIRE)– Cambrooke Therapeutics Inc., a leader in therapeutic nutrition for inborn errors of metabolism and ketogenic diet therapy, announces the launch of Tylactin™ COMPLETE Bars, a nutritionally complete medical food, available in a convenient portable format, for the dietary management of …

Plus »

Transgene and Bristol-Myers Squibb Announce Clinical Research Collaboration to Evaluate TG4010 in Combination with Opdivo and Standard Chemotherapy in First Line Non-Small Cell Lung Cancer

Tuesday, April 25th 2017 at 5:30am UTC NEW YORK & STRASBOURG, France–(BUSINESS WIRE)– Bristol-Myers Squibb Company (NYSE:BMY) and Transgene today announced a new clinical research collaboration to evaluate the safety, tolerability and efficacy of Transgene’s investigational therapeutic vaccine TG4010 in combination with Bristol-Myers Squibb’s Opdivo (nivolumab) + standard chemotherapy (CT) …

Plus »

AtriCure’s AtriClip System Surpasses 100,000 Units Sold Worldwide

Tuesday, April 25th 2017 at 12:00pm UTC AtriClip is the most widely used device globally for left atrial appendage management MASON, Ohio–(BUSINESS WIRE)– AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments for atrial fibrillation (Afib) and left atrial appendage management, today announced it has sold more than 100,000 …

Plus »
Macbook Pro
* Intel Core i7 (3.8GHz, 6MB cache)
* Retina Display (2880 x 1880 px)
* NVIDIA GeForce GT 750M (Iris)
* 802.11ac Wi-Fi and Bluetooth 4.0
* Thunderbolt 2 (up to 20Gb/s)
* Faster All-Flash Storage (X1)
* Long Lasting Battery (9 hours)
BIENVENUE !
Vous appréciez cet article ? Faites-nous part de vos commentaires.
Recevez nos alertes, nos dernières actualités, suivez-nous, enregistrez-vous gratuitement, rejoignez notre communauté. Merci à vous !
ARE YOU READY? GET IT NOW!
Increase more than 500% of Email Subscribers!
Your Information will never be shared with any third party.
DÉCOUVREZ LA SOLUTION STRATA !
PGlmcmFtZSB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBzcmM9Imh0dHA6Ly93d3cuZWVpLWJpb3RlY2hmaW5hbmNlcy5jb20vd3AtY29udGVudC91cGxvYWRzLzIwMTUvMDcvU2F0cmEtMi5tcDQiIGZyYW1lYm9yZGVyPSIwIiBhbGxvd2Z1bGxzY3JlZW4+PC9pZnJhbWU+
Retrouvez nous sur http://stratahealth.com/fr/
Un ensemble de solutions performantes
pour assurer le continuum de vos données.
SUIVEZ-NOUS, ENREGISTREZ-VOUS !
PGlmcmFtZSB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBzcmM9Imh0dHA6Ly93d3cueW91dHViZS5jb20vZW1iZWQvajhsU2NITzJtTTAiIGZyYW1lYm9yZGVyPSIwIiBhbGxvd2Z1bGxzY3JlZW4+PC9pZnJhbWU+
All rights reserved © Company Name, 2014
Concours Genopole Young Biotech Award
* 100 000 € pour la meilleure Biotech
* Réservé aux biotechs hors santé
* 6 mois d'hébergement gratuit
* Un accompagnement personnalisé
* Etude de marché offerte
* Expertise du projet par EY
* Et nombre d'autres avantages...